Belvedere Trading
GRTX

Belvedere Trading’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Belvedere Trading’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,200
Closed -$75.5K – 1049
2023
Q2 		$75.5K Buy
+24,200
New +$72K ﹤0.01% 478

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Belvedere Trading's GRTX Position: Q3 2023 in Review

Belvedere Trading sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 21,314 shares — an estimated $66.5K sold.

Belvedere Trading first reported a position in GRTX in Q4 2021 and held it in 3 quarters. The position peaked at $255K in Q4 2021. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

  • Belvedere Trading reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Belvedere Trading sold 21,314 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $66.5K.
  • Belvedere Trading first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Belvedere Trading's Galera Therapeutics, Inc. Common Stock position peaked at $255K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Belvedere Trading's 13F filing for Q3 2023, filed 27 Oct 2023.